Method of treatment of atopic disease

• US 5,709,853 A
• Filed: 11/03/1995
• Issued: 01/20/1998
• Est. Priority Date: 01/28/1994
• Status: Expired due to Term

• Current Assignee: Toray Industries Incorporated
• Original Assignee: Toray Industries Incorporated
• Inventors: Kawashima, Yoshiharu, Iino, Shiro
• Primary Examiner(s): Goldberg, Jerome D.
• Application Number:
  US08/525,755
• Time in Patent Office: 809 Days
• Field of Search: 424/85.6
• US Class Current: 424/85.6
• CPC Class Codes: A61K 38/215 IFN-beta
• CPC Class Codes: A61K 8/64 Proteins; Peptides; Derivatives or degradation products thereof
• CPC Class Codes: A61P 17/00 Drugs for dermatological disorders
• CPC Class Codes: A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• CPC Class Codes: A61P 37/08 Antiallergic agents antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• CPC Class Codes: A61Q 19/00 Preparations for care of the skin

Abstract

The present invention relates to pharmaceutical composition for atopic disease comprising interferon β as an active ingredient, because it significantly improved dermatic symptoms of atopic dermatitis, decreased the number of blood eosinocytes remarkably which is a main causative factor of allergic reactions, and exhibited a fast-acting and prolonged effect.

Claims

1. A method of treating atopic disease comprising administering to a patient in need thereof an effective dose of interferon-β

.

2. The method defined in claim 1 wherein said atopic disease is atopic dermatitis or atopic asthma.

3. A method of treating atopic disease comprising administering to a patient in need thereof an effective dose of a pharmaceutical composition containing a concentrated and purified interferon-β

combined with a pharmaceutically acceptable carrier.